Physician profile
Devin Parker Leland
NPI 1568090454
$12,408.35
in general payments reported to CMS, 2019-2025
8 companies · $6,174 in 2025
The $6,174 reported for 2025 was more than what 83% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,877 · 2022: $518 · 2023: $524 · 2024: $315 · 2025: $6,174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $5,313 · Food and Beverage: $1,421 · Education: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $5,312.50 |
| Food and Beverage | $1,420.86 |
| Education | $279.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $5,412.14 | 2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Stryker Corporation | $3,950.21 | 2021-2025 | Mako, Hoffmann, Gamma |
| Medical Device Business Services, INC. | $2,375.18 | 2021-2024 | |
| Depuy Synthes Sales INC. | $370.79 | 2022-2025 | Tfn-Advance |
| Prism Medical | $113.59 | 2025 | |
| Medtronic, INC. | $74.02 | 2023 | Unid_pass |
| Fx Shoulder Solutions, INC | $61.59 | 2025 | |
| Arthrex, INC. | $50.83 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devin Leland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.